Pharm One Liners Flashcards

(436 cards)

1
Q

Relates the amount of drug in the body to the plasma concentration

A

Volume of distribution (VD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Plasma concentration of a drug at a given time

A

Cp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The ratio of the rate of elimination of a drug to its plasma concentration

A

Clearance (CL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hepatic metabolism of the drug before it reaches the systemic circulation

A

First pass effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The fraction of unchanged drug that reaches systemic circulation after administration

A

Bioavailability (F)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When the rate of drug input equals the rate of drug elimination

A

Steady state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Different steps of Phase I

A

Oxidation, reduction, hydrolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Name 3 Phase II conjugation reactions

A

Glucuronidation, acetylation, glutathione conjugation, glycine conjugation, sulfation, methylation, water conjugation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Constant percentage of drug metabolized per unit time

A

First order kinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Constant amount of drug metabolized per unit time

A

Zero order kinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Target plasma concentration times (volume of distribution divided by bioavailability)

A

Loading dose (Cp*(Vd/F))

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Concentration in the plasma times (clearance divided by bioavailability)

A

Maintenance dose (Cp*(CL/F))

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Strength of interaction between drug and its receptor

A

Affinity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Selectivity of a drug for its receptor

A

Specificity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Amount of drug necessary to elicit a biologic effect compared with another drug

A

Potency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ability of a drug to produce maximal response after binding to the receptor

A

Full agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Ability to produce less than maximal response after binding to the receptor

A

Partial agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Ability to bind reversibly to the same site as the drug and without activating the effector system

A

Competitive antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Ability to bind irreversibly to the active site or bind to a site distinctly separate from the agonist binding site

A

Noncompetitive antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Mechanism of action utilizes ligand gated ion channels

A

Acetylcholine, nicotine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Dose that produces therapeutic response in 50% of the population

A

ED50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Dose that is toxic to 50% of the population

A

TD50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Dose that is lethal to 50% of the population

A

LD50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Window between therapeutic effect and toxic effect

A

Therapeutic index

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Drugs that have a high margin of safety is indicated by
High therapeutic index
26
Drugs that have a narrow margin of safety is indicated by
Low therapeutic index
27
Antidote for lead poisoning
Edetate calcium disodium, succimer, or dimercaprol
28
Antidote for cyanide poisoning
Nitrates, thiosulfate, hydroxocobalamin
29
Antidotefor anticholinergic poisoning
Physostigmine
30
Antidote for iron salt poisoning
Deferoxamine
31
Antidote for arsenic, mercury, and gold poisoning
Dimercaprol, succimer
32
Antidote for Wilson's disease (copper poisoning)
Penicillamine
33
Antidote for methanol and ethylene glycol toxicity
Fomepizole, ethanol
34
Antidote for tricyclic antidepressants (TCA)
Sodium bicarbonate (alkalinize plasma)
35
Antidote for carbon monoxide poisoning
100% O2 and hyperbaric O2
36
Antidote for digitalis toxicity
Digibind
37
Antidote for beta-blocker overdose
Glucagon
38
Method to reduce salicylate intoxication
Sodium bicarbonate (alkalinize urine), dialysis
39
Muscarinic that is very lipid soluble and used in glaucoma
Pilocarpine
40
Muscarinic used to treat dry mouth in Sjögren's syndrome
Pilocarpine or Cevimeline
41
Cholinesterase inhibitor, short duration of action, used in diagnosis of myasthenia gravis
Edrophonium
42
Cholinesterase inhibitor, intermediate duration of action, used off-label for postoperative paralytic ileus and urinary retention
Neostigmine
43
Cholinesterase inhibitor, lipid soluble, indicated for atropine overdose and glaucoma
Physostigmine
44
Treatment of myasthenia gravis and sometimes used prophylactically for organophosphate poisoning in chemical warfare
Pyridostigmine
45
Organophosphate, indicated for glaucoma but not used much clinically due to long duration of action
Echothiophate
46
Insecticide organophosphate
Malathion, parathion
47
The most important cause of acute deaths in cholinesterase inhibitor toxicity
Respiratory failure
48
Used in treatment of muscarinic symptoms in organophosphate overdose
Atropine
49
Mechanism of action of atropine
Nonselective antimuscarinic
50
Antimuscarinic indicated for overactive bladder muscle dysfunction
Oxybutynin
51
Toxicity of anticholinergics
Anti-DUMBBELSS
52
Another pneumonic for anticholinergic toxicity
"dry as a bone, red as a beet, mad as a hatter, hot as a hare, blind as a bat"
53
Atropine fever is the most dangerous effect and can be lethal in this population group
Infants
54
Contraindications to use of atropine
Infants, closed angle glaucoma, prostatic hypertrophy
55
Pneumonic for beta receptors
You have 1 heart (Beta 1) and 2 lungs (Beta 2)
56
Drug of choice for anaphylactic shock
Epinephrine
57
Indirect acting sympathomimetic, reuptake inhibitor, commonly abused, indicated for attention deficit disorder and weight reduction
Methamphetamine
58
Alpha agonist indicated for nasal congestion, hypotension, and mydriasis induction
Phenylephrine
59
Short acting beta 2 agonist, drug of choice for acute asthma
Albuterol
60
Longer acting beta 2 agonist, indicated for prophylaxis of asthma
Salmeterol
61
Its ability to increase heart rate makes it useful as adjunct therapy for acute heart failure and hypovolemia or septic shock
Beta 1 agonist
62
Indicated for symptomatic orthostatic hypotension
Midodrine
63
Beta 2 agonist used to suppress premature labor, but cardiac stimulatory effects may be hazardous to mother and fetus
Terbutaline
64
Indirect acting sympathomimetic, improves urinary continence in children and elderly with enuresis
Ephedrine
65
Beta agonists used in acute congestive heart failure
Dobutamine and dopamine
66
Beta 1 agonist toxicity
Sinus tachycardia and serious arrhythmias
67
Beta 2 agonist toxicity
Skeletal muscle tremor
68
Irreversible, nonselective alpha-blocker indicated for pheochromocytoma
Phenoxybenzamine
69
Reversible, nonselective alpha blocker indicated for pheochromocytoma
Phentolamine
70
Blocks alpha 1 and beta receptors and indicated for the treatment of CHF
Labetalol and carvedilol
71
Beta blockers with partial agonist activity, can bronchodilate and may have an advantage treating patients with asthma
Pindolol and acebutolol
72
Short-acting beta blocker that can be given parenterally
Esmolol
73
Clinical uses of these agents include treatment of hypertension, angina, arrhythmias, and chronic congestive heart failure
Beta blockers
74
Beta-blockers should be used cautiously in
Asthma (bronchospastic effects), diabetes (block signs of hypoglycemia) and peripheral vascular disease
75
Beta blockers are used for this type of angina attack
Classic (exertional) angina
76
A nonselective beta blocker with alpha 1 blocking effect indicated for congestive heart failure
Carvedilol
77
This class of drugs inhibit angiotensin-converting enzyme
ACE inhibitors
78
Mechanism of action of calcium channel blockers
Block L-type calcium channels
79
Side effects of methyldopa
Positive Comb's hemolytic anemia, SLE-like syndrome, CNS depression
80
Side effect of clonidine
Rebound hypertension, sedation, dry mouth
81
Direct vasodilator of arteriolar smooth muscle by increasing cGMP and inhibit IP3-induced calcium release from the sarcoplasmic reticulum
Hydralazine
82
Arterial vasodilator that works by opening K+ channels
Minoxidil
83
Side effect of minoxidil
Hypertrichosis
84
IV nitrate used in hypertensive crisis
Nitroprusside
85
Nitroprusside vasodilates
Arteries and veins
86
Side effect of nitroprusside
Cyanide poisoning
87
Drugs used in the management of exertional (classic) angina
Nitrates, calcium channel blockers, beta blockers
88
Aspirin reduces mortality in unstable angina by
Inhibiting platelet aggregation
89
Nitrate free intervals are needed due to
Tolerance
90
Side effects of nitrates
Reflex tachycardia, hypotension, flushing, and throbbing headache due to meningeal artery dilation
91
Mechanism of action of cardiac glycosides (eg. digoxin)
Inhibit Na+/K+ ATPase and indirectly increase intracellular calcium and cardiac contractility
92
Indication of digoxin
Atrial fibrillation and congestive heart failure
93
Digoxin toxicity can be precipitated by
Hypokalemia
94
Phosphodiesterase (PDE3) inhibitors indicated for acute congestive heart failure; long term use is associated with increased mortality
Amrinone and milrinone
95
Side effect of amrinone and milrinone
Thrombocytopenia
96
Agent used in acutely decompensated congestive heart failure resembling natriuretic peptide
Nesiritide
97
Mechanism of action of class II antiarrhythmics
Beta -blockers
98
Mechanism of action of class IV antiarrhythmics
Calcium channel blockers
99
Major drug interaction with quinidine
Increases concentration of digoxin
100
Contraindication of disopyramide use
Heart failure
101
Used as last line antiarrhythmic agents due to proarrhythmic property; strongest sodium channel blocker
Class IC (flecainide, propafenone)
102
Anti-arrhythmic agents that decrease mortality
B-blockers
103
Used intravenously for acute tachycardia during and post- surgery
Esmolol
104
Antiarrhythmic effective in most types of arrhythmia
Amiodarone
105
Class III antiarrhythmic that exhibits properties of all 4 classes
Amiodarone
106
Antiarrhythmic that exhibits Class II and III properties
Sotalol
107
Side effect of sotalol
prolongs QT interval
108
Drug of choice for narrow complex paroxysmal supraventricular tachycardia (PSVT)
Adenosine
109
Mechanism of action of adenosine
Activates G-protein coupled K+ channels in atrium, SA and AV node
110
Anti-arrhythmic with <10 second duration of action
Adenosine
111
Drug of choice for early after depolarizations (Torsade)
Magnesium sulfate
112
HMG CoA reductase inhibitors are contraindicated in
Pregnancy
113
Concurrent use of fibrates and statins increases risk of
Rhabdomyolysis
114
Class of agents for cholestyramine, colestipol, colesevalem
Bile acid-binding resins
115
Major nutritional side effect of bile acid-binding resins
Impair absorption of fat soluble vitamins (A,D,E,K)
116
Side effect of fenofibrate and gemfibrozil
Gallstone formation
117
Cutaneous flush due to niacin can be reduced by pretreatment with
NSAIDs
118
Inhibits intestinal cholesterol absorption by inhibiting Niemann Pick C1 Like 1 (NPC1L1) Protein
Ezetimibe
119
Mechanism of action of aspirin
Irreversibly blocks COX1 and COX2
120
Agent used to treat myocardial infarction (MI) and to reduce incidence of subsequent MI
Aspirin
121
Antiplatelet drug reserved for patients allergic to aspirin
Ticlopidine
122
Side effect for ticlopidine
Neutropenia and agranulocytosis
123
Irreversible inhibitor of platelet P2Y12 receptors; effective in preventing transient ischemic attack
Clopidogrel and ticlopidine
124
Phosphodiesterase inhibitor indicated for intermittent claudication
Dipyridamole, cilostazol
125
Block glycoprotein IIb/IIIa involved in platelet cross-linking
Abciximab, tirofiban and eptifibatide
126
Route of administration of warfarin
Oral
127
Contraindication of warfarin
Pregnancy
128
Anticoagulant of choice in pregnancy
Heparin
129
Routes of administration of heparin
IV and SC
130
Side effect of both warfarin and heparin
Bleeding
131
Two anticoagulant used for prophylaxis and treatment of thrombosis in patients with heparin-induced thrombocytopenia
Bivalirudin, argatroban
132
Thrombolytic used for acute myocardial infarction and ischemic (non-hemorrhagic) cerebral vascular accident (stroke)
Alteplase
133
Side effect of tissue plasminogen activators
cerebral hemorrhage
134
Thrombolytic that can cause allergic reaction and non-selective systemic fibrinolysis
Streptokinase
135
Carbonic anhydrase inhibitor
Acetazolamide
136
Mechanism of action of loop diuretics
inhibits Na+/K+/2Cl- cotransporter
137
Diuretic used in hypertensive patients with renal failure
Loop diuretics (furosemide, ethacrynic acid, butmetanide)
138
Aminoglycosides used with loop diuretics potentiate this adverse effect
Ototoxicity
139
Mechanism of action of thiazide diuretics
Inhibit Na+/Cl- cotransport
140
Diuretic used as first line for treatment of hypertension
Thiazides
141
Class of drugs that may cause cross-sensitivity with thiazide diuretics
Sulfonamides
142
Mechanism of action of spironolactone
Inhibit mineralocorticoid (aldosterone) receptor resulting in inhibition of Na/K-ATPase and ENaC synthesis
143
Diuretics work in congestive failure by
Reducing preload
144
Agents used for syndrome of inappropriate antidiuretic hormone (SIADH) secretion
Tolvaptan and conivaptan
145
An early generation tetracycline that may be used for chronic persistant syndrome of inappropriate antidiuretic hormone (SIADH) secretion
demeclocycline
146
Side effect of demeclocycline
Stunted bone growth and teeth discoloration for children under 8 years of age
147
Antibacterials for optimal treatment of acute uncomplicated cystitis
Nitrofurantoin, trimethoprim-sulfamethoxazole, fosfomycin
148
Antibacterials for optimal treatment of acute pyelonephritis
Fluoroquinolones (ciprofloxacin, levofloxacin), trimethoprim-sulfamethoxazole
149
Mechanism of action of penicillin
Block cell wall synthesis by inhibiting transpeptidase and block peptidoglycan cross-linkage
150
Penicillins active against penicillinase secreting bacteria
Methicillin, nafcillin, and dicloxacillin
151
Class of antibiotics that have 10% cross sensitivity with penicillins
Cephalosporins
152
Penicillins active against pseudomonas
Piperacillin and ticarcillin
153
Beta lactam that can be used in penicillin-allergic patients
Aztreonam
154
Side effect of imipenem
Seizures
155
Drug of choice for treatment of serious pseudomembranous colitis
Oral vancomycin
156
Antibiotic causing red-man syndrome, and prevention
Vancomycin, can be prevented by infusion | at a slow rate and antihistamines
157
Drug causes teeth discoloration
Tetracycline
158
Mechanism of action of tetracycline
Decreases protein synthesis by binding to 30S ribosome and prevent binding of tRNA
159
Two toxicities of aminoglycosides
Nephro and ototoxicity
160
Aminoglycoside less used due to its irreversible vestibular toxicity
Streptomycin
161
Mechanism of action of macrolides (erythromycin, clarithromycin)
Inhibit protein synthesis by binding to 23S rRNA of 50S ribosome subunit
162
Drug of choice for Legionnaires' disease
Azithromycin or levofloxacin
163
Drug notorious for causing pseudomembranous colitis
Clindamycin
164
Drug that causes gray baby syndrome and aplastic anemia
Chloramphenicol
165
Inhibits isoleucyl tRNA and used topically for impetigo
Mupirocin
166
Side effect of metronidazole when given with alcohol
Disulfiram-like reaction
167
Neurotoxicity with isoniazid can be prevented by
Administration of Vit B6 (pyridoxine)
168
Side effect of isoniazid
Systemic lupus erythematosus, peripheral neuritis, hepatitis
169
Drug of choice for leprosy
Dapsone
170
Toxicity of amphotericin
Nephrotoxicity
171
Side effect of ketoconazole only in men
Gynecomastia
172
Mechanism of action of nystatin
Binds to ergosterol and creates a pore in fungal membrane
173
Drug used in exoerythrocytic cycle of malaria
Primaquine
174
Drug of choice for cytomegalovirus (CMV) treatment
Ganciclovir
175
Side effect of ganciclovir
Myelosuppression (neutropenia)
176
First line for the treatment of chronic hepatitis B virus (HBV) infections
IFN + nucleoside reverse transcriptase inhibitor (NRTI)
177
First line for the treatment of chronic hepatitis C virus (HCV) infections in genotype 1 patients
IFN + ribavirin + protease inhibitor (-previr)
178
HIV medication used to reduce mother-to-child transmission during birth
Zidovudine, nevirapine
179
Antivirals associated with neutropenia
Ganciclovir, zidovudine, interferon
180
Two nucleoside reverse transcriptase inhibitors approved for both HIV and HBV infections
Tenofovir, lamivudine
181
Antiviral/antiretroviral that are teratogens
Efavirenz, and ribavirin
182
Anti-retroviral with a dose limiting toxicity of pancreatitis and peripheral neuropathy
Didanosine
183
Three anti-retroviral agents associated with fatal Stephen-Johnson syndrome
Nevirapine, efavirenz, etravirine
184
Anti-retroviral class that causes drug interactions by causing induction of CYP enzymes
Non-nucleos(t)ide reverse transcriptase inhibitors
185
Class of drugs that reversibly inhibit cyclooxygenase (COX)
NSAIDS
186
Mechanism of action of non-steroidal antiinflammatory drugs (NSAIDS)
inhibit prostaglandin synthesis by inhibiting cyclo-oxygenase (cox)
187
Four main actions of NSAIDS
Anti-inflammatory, analgesia, antipyretic and antiplatelet activity
188
Irreversible, nonselective COX inhibitor that displays zero-order kinetics of elimination
Aspirin
189
The reason why aspirin is contraindicated in children with viral infection
Potential for development of Reye's syndrome
190
Two side effects of salicylates
Tinnitus, GI bleeding
191
Prostaglandin analog indicated for severe pulmonary hypertension
Epoprostenol (PGI2)
192
NSAID available orally, IM, IV, nasally, and ophthalmically
Ketoralac
193
NSAID used mostly for anesthesia and has limited duration (<5 days) due to nephrotoxicity
Ketoralac
194
Difference between COX 1 and COX 2
COX 1: constitutive, COX 2: inducible during inflammation
195
Selective COX 2 inhibitor
Celecoxib
196
COX 2 inhibitors may have reduced risk of
Gastric ulcers and GI Bleeding
197
COX 2 inhibitors should be used cautiously in patients with
Pre-existing cardiac or renal disease
198
Side effect of acetaminophen
Hepatotoxicity
199
Major side effect of zileuton that limits its use
Liver toxicity
200
Two leukotrienes (LTD4) receptor antagonists used in asthma
Zafirlukast and montelukast
201
First line drugs for acute gout
Indomethacin, naproxen
202
NSAID avoided in gout because low doses increases uric acid levels
Aspirin
203
Mechanism of action of colchicine
Inhibits microtubule assembly, decreases leukocyte migration and phagocytosis
204
Side effects of colchicine
Diarrhea, liver toxicity, myelosuppression
205
Agent used to treat chronic gout by increasing uric acid excretion through inhibition of URAT1 anion transporter
Probenecid
206
Recombinant uricase that enhances uric acid metabolism and indicated for gout refractory to conventional therapy
Pegloticase
207
A mixture of two agents with one agent active for rheumatic disease and the other for inflammatory bowel disease
Sulfasalazine
208
Alternative to methotrexate as 1st line for rheumatoid arthritis through inhibition of dihydroorotate dehydrogenase, which leads to decreased pyrimidine synthesis
Leflunomide
209
Side effect of penicillamine
Hypersensitivity (rash), nephrotoxicity, myopathy, myelosuppression
210
Anti-malarial drug used in rheumatoid arthritis
Hydroxychloroquine
211
Side effect of hydroxychloroquine
Retinopathy
212
Two drugs that bind and prevent action of tumor necrosis factor alpha (TNF-alpha)
Infliximab and etanercept
213
Structurally related to acetylcholine, used to produce muscle paralysis in order to facilitate surgery or artifical ventilation. Full doses lead to respiratory paralysis and require ventilation
Neuromuscular blocking drugs
214
This class of agents block acetylcholine receptors at motor endplates and its effects can be reversed by cholinesterase inhibitors
Nondepolarizing blockers
215
Non-depolarizing neuromuscular blocker with long duration of action and is most likely to cause histamine release
Tubocurarine
216
Non-depolarizing neuromuscular blocker with short duration of action
Mivacurium
217
Two non-depolarizing blockers that undergo Hofmann elimination, which is useful for patients with renal and hepatic deficiency
Atracurium, cisatracurium
218
Non-depolaring neuromuscular blocker with long duration of action that can block muscarinic receptor in the heart
Pancuronium
219
These drugs strongly potentiate and prolong effect of neuromuscular blockers
Inhalation anesthetics (isoflurane), antibiotics (aminoglycosides, tetracyclines)
220
Depolarizing blocker that causes muscle relaxation and paralysis and can cause postoperative muscle pain
Succinylcholine
221
Two life-threatening side effects of succinylcholine
Hyperkalemia, malignant hyperthermia
222
During Phase I depolarizing block this class of agents enhance muscle paralysis, but during Phase II block they may reverse muscle paralysis
Cholinesterase inhibitors
223
Drug of choice for reversal of non-depolarizing neuromuscular blockade
Neostigmine
224
Enzyme which theophylline inhibits
Phosphodiesterase
225
Growth hormone analog used in growth hormone deficiency
Somatropin
226
Somatostatin analog used for acromegaly, carcinoid, glucagonoma and other growth hormone-producing pituitary tumors
Octreotide
227
Gonadotropin-releasing hormone analog used for infertility (pulsatile administration) or suppression of gonadotropin production (continuous administration)
Leuprolide
228
Competitive antagonists at gonadotropin releasing hormone receptors used to prevent LH surge during controlled ovarian hyperstimulation
Ganirelix
229
An isomer of T3 which may be used in myxedema coma
Liothyronine (T3)
230
Thioamide agents used in hyperthyroidism
Methimazole and propylthiouracil (PTU)
231
Can be effective for short term therapy of thyroid storm, but after several weeks of therapy causes an exacerbation of hyperthyroidism
Iodide salts (potassium iodide)
232
Permanently cures thyrotoxicosis, patients will need thyroid replacement therapy thereafter. Contraindicated in pregnancy
Radioactive iodine
233
Used for the symptomatic treatment of thyrotoxicosis by blocking cardiac adverse effects
Beta-blockers such as propranolol and esmolol
234
Used for Addison's disease, congenital adrenal hyperplasia inflammation, immune suppression, and asthma
Glucocorticoids
235
Two short-acting glucocorticoids
Hydrocortisone (cortisol), cortisone
236
Four intermediate-acting glucocorticoids
Prednisone, prednisolone, methylprednisolone, and triamcinolone
237
Two long-acting glucocorticoids
Betamethasone, dexamethasone
238
Mineralocorticoids
Fludrocortisone and deoxycorticosterone
239
Inhibits conversion of cholesterol to pregnenolone therefore inhibiting corticosteroid synthesis
Aminoglutethimide
240
Antifungal agent used to inhibit adrenal and gonadal steroid synthesis
Ketoconazole
241
Selective inhibitor of 11-hydroxylation and interferes with cortisol and corticoterone synthesis; used for adrenal function tests and is the only adrenal-inhibiting medication that can be administered to pregnant women with Cushing's syndrome
Metyrapone
242
Glucoroticoid receptor antagonist that is used as an antiabortifacient due to its strong antiprogestin activity
Mifepristone (RU486)
243
Three rapid-acting insulin used for postprandial glycemia
Aspart, lispro, glulisine
244
Short-acting insulin used intravenously for ketoacidosis
Regular insulin
245
Two long-acting insulin preparations that provide basal glycemia control
Glargine, detemir
246
Major side effect of insulin
Hypoglycemia
247
First generation sulfonylurea that is safest for elderly diabetics due to its short half-life
Tolbutamide
248
First generation sulfonylurea contraindicated in elderly diabetics because of very long half-life
Chlorpropamide
249
Three second generation sulfonylureas
Glyburide, glipizide, glimepiride
250
Mechanism of action of sulfonylureas
Close K+ channels, depolarize cell, open voltage-gated Ca2+ channels, release insulin
251
Common side effect of first generation sulfonylureas
Disulfiram-like reactions with alcohol use
252
Common side effect of second generation sulfonylureas
Hypoglycemia
253
A meglitinide insulin secretagogue that has no sulfur in its structure and may be used in type 2 diabetics with sulfonylurea allergy
Repaglinide
254
A D-phenylalanine derivative insulin secretagogue that is useful for type 2 diabetics with very reduced renal function
Nateglinide
255
Mechanism of action of repaglinide and nateglinide
Close K+ channels, depolarize cell, open voltage-gated Ca2+ channels, release insulin
256
Mechanism of action of metformin
¯ gluconeogenesis, ­ peripheral glucose uptake; increase insulin sensitivity
257
Two thiazolidinediones
Pioglitazone, rosiglitazone
258
Mechanism of action of thiazolindinediones
Activate PPAR-gamma, ­ transcription of insulin-responsive genes, ­ GLUT4 glucose transporter, ­ insulin sensitivity
259
Side effect of thiazolindinediones
Weight gain, edema, heart failure, hepatotoxicity
260
Two alpha-glucosidase inhibitors
Acarbose, miglitol
261
Mechanism of action of alpha-glucosidase inhibitors
Act on intestine, delay digestion and absorption of glucose
262
Side effect of alpha-glucosidase inhibitors
Flatulence , diarrhea, abdominal cramps
263
Amylin analog that delays gastric emptying and suppresses glucagon release
Pramlintide
264
Two glucagon-like polypeptide-1 (GLP-1) analogs that increase insulin secretion and suppress postprandial glucagon release
Exenatide, liraglutide
265
Three dipeptidyl peptidase-4 (DPP-4) inhibitors that reduce breakdown of glucagon-like polypeptide-1, resulting in increased insulin secretion and suppress postprandial glucagon release
Sitagliptin, saxagliptin, linagliptin
266
Bisphosphonates
Alendronate and -dronates
267
Mechanism of action of bisphosphonates
Inhibits osteoclast activity and prevent bone resorption
268
Uses of bisphosphonates
Osteoporosis, Paget's disease, hyperglycemia
269
Major side effects of bisphosphonates
Corrosive esophagitis, osteonecrosis of the jaw
270
First generation bisphosphonate when used long-term causes osteomalacia
Etidronate
271
Vitamin given with calcium to ensure proper absorption
Vitamin D
272
Its use can increase risk of endometrial and breast cancer, cause postmenopausal uterine bleeding, but can stabilize bone mineral loss
Estrogen
273
Antiestrogen drugs used for treatment of infertility in anovulatory women
Clomiphene
274
Common side effect of tamoxifen and clomiphene
Hot flushes
275
Two estradiol derivatives with higher oral bioavailability and longer half-lives that are primarily used as oral contraceptives
Ethinyl estradiol and mestranol
276
5 alpha-reductase inhibitor used for benign prostatic hyperplasia and male pattern baldness
Finasteride
277
Partial androgen agonist used for endometriosis and hereditary angioedema
Danazol
278
Androgen receptor antagonist used to treat prostate cancer
Flutamide
279
Androgen receptor antagonist used for hirsutism in females
Cyproterone
280
A class of endogenous substances that include histamine, serotonin, prostaglandins, and vasoactive peptides that work in autocrine or paracrine manner
Autacoids
281
Two peptide that increase capillary permeability and edema
Bradykinin and histamine
282
Most common side effect of 1st generation antihistamines
Sedation, anticholinergic
283
1st generation antihistamine that is least sedating
Chlorpheniramine
284
Major indication for H1 antihistamines
IgE mediated allergic reaction (allergic rhinitis, urticaria)
285
Antihistamine that is indicated for allergies, motion sickness, and insomnia
Diphenhydramine
286
Antihistamine with motion sickness as the only indication
Dimenhydrinate
287
Indication for H2 antagonists
Acid reflux disease, duodenal ulcer and peptic ulcer disease
288
Location of serotonin type-1 (5HT-1) receptors
Mostly in the brain
289
Ergot alkaloid indicated for migraine headaches
Ergotamine
290
Reason ergot alkaloids are contraindicated in pregnancy
Uterine contractions
291
Two side effects of ergot alkaloids
Prolonged vasospasm and hallucinations resembling psychosis
292
Two drugs that may be used off-label for ischemia and gangrene caused by ergot alkaloids overdose
Nitroprusside, nitroglycerin
293
Serotonin receptor responsible for serotonin syndrome
5HT2
294
Location of serotonin type-3 (5HT-3) receptors
GI tract, vomiting center of medulla
295
Ganglion blockers that were indicated (but not anymore) for severe hypertension
Hexamethonium, trimethaphan
296
Two direct-acting cholinomimetics that increase aqueous outflow through ciliary muscle contraction and opening of trabecular meshwork
Pilocarpine, carbachol
297
Two indirect-acting cholinomimetics that increase aqueous outflow through ciliary muscle contraction and opening of trabecular meshwork
Physostigmine, echothiophate
298
Nonselective alpha agonist that decreases aqueous production
Epinephrine
299
Selective alpha 2 agonist that decreases aqueous production
Brimonidine
300
Carbonic anhydrase inhibitor used to decrease aqueous humor production
Acetazolamide
301
Common side effect of sedative hypnotics
CNS depression
302
Occurs when sedative hypnotics are used long-term
Tolerance and physical dependence
303
Main route of metabolism for benzodiazepines
Hepatic
304
Useful side effect of benzodiazepines in patients undergoing stressful procedures or surgery
Anterograde amnesia
305
Three benzodiazepines that are metabolized only by Phase II conjugation and therefore is useful in elderly patients
Lorazepam, oxazepam, and temazepam
306
Two benzodiazepines that have active metabolites with long half-lives
Diazepam, chlordiazepoxide
307
Clinical uses of benzodiazepines
Anxiety, insomnia, alcohol detoxification, status epilepticus, spasticity
308
Reason why benzodiazepines are safer than barbiturates
Benzodiazepines work only in presence of GABA
309
Most serious side effects of barbiturates
Respiratory and cardiovascular depression
310
Barbiturates may precipitate this hematologic condition
Porphyria
311
Barbiturates decrease the effectiveness of many other drugs via this pharmacokinetic property
Induce CYP450
312
Effect of benzodiazepines and barbiturates on sleep architecture
Suppress REM
313
Mechanism of action of zolpidem
Activates BZ1 subtype of GABAA receptor
314
Antiepileptic drug used as first line for trigeminal neuralgia
Carbamazepine
315
Antiepileptic drug that can induce CYP450, is teratogenic, and can cause diplopia, ataxia, and blood dyscrasias; follows first order kinetics of elimination
Carbamazepine
316
Mechanism of action of Phenytoin, Carbamazepine, Lamotrigine
Blocks sodium channels
317
Mechanism of action of valproic acid
Blocks sodium channels, T-type calcium channels, and increase GABA concentration
318
Antiepileptic drug that can cause fatal hepatotoxicity and neural tube defects
Valproic acid
319
Mechanism of action of Ethosuximide
Blocks T-type calcium channels
320
Antiepileptic drugs that may also be used for bipolar disorder
Valproic acid, carbamazepine, gabapentin
321
Serious side effect of lamotrigine that makes it require slow titration
Stevens-Johnson syndrome
322
Side effects of these drugs include nausea and vomiting, euphoria, dependence, tolerance, sedation, respiratory depression, constipation
Opioids
323
Strong opioid agonists
Morphine, methadone, meperidine, and fentanyl
324
Opioids used in anesthesia
Morphine and fentanyl
325
Opioid with antimuscarinic activity
Meperidine
326
Opioid that can cause hyperpyrexic coma with MAOI and serotonin syndrome with SSRI
Meperidine
327
Partial opioid agonist that has a long duration of action and is resistant to naloxone reversal
Buprenorphine
328
Opioids indicated for use as antitussive
Dextromethorphan, Codeine
329
Opioids indicated for use as antidiarrheal
Diphenoxylate, Loperamide
330
Directly proportional to the potency of inhalation anesthetics
Lipid solubility
331
Inversely proportional to the potency of inhalation anesthetics
Minimal alveolar concentration (MAC)
332
Inversely proportional to the rate of induction and recovery of inhalation anesthetics
Blood:gas partition coefficient
333
Mechanism of action of inhalation anesthetics
Potentiation of GABA at GABAA receptors; also reduce Na and Ca influx
334
Currently the only non-halogenated inhalation anesthetic
Nitrous oxide
335
Inhalation anesthetic with the most analgesic activity
Nitrous oxide
336
Inhalation anesthetic with the least respiratory and cardiovascular depression and therefore is used frequently as a component of balanced anesthesia
Nitrous oxide
337
Inhalation anesthetic that can cause fatal hepatotoxicity and cardiac arrhythmia and is no longer used in the US
Halothane
338
Inhalation anesthetic that is withdrawn from the market due to fatal nephrotoxicity
Methoxyflurane
339
Inhalation anesthetic that at high concentrations can produce CNS excitation, leading to seizures
Enflurane
340
Close to ideal inhalation anesthetic that exhibits rapid and smooth induction and recovery, with little organ system toxicity
Sevoflurane
341
Barbiturate used for the induction of anesthesia
Thiopental
342
A short-acting benzodiazepine commonly used adjunctively with inhalation anesthetics and opioid analgesics for a balanced anesthesia
Midazolam
343
Produces both rapid anesthesia and recovery, has antiemetic activity, but may cause marked hypotension
Propofol
344
Mechanism of action of the intravenous anesthetic that causes dissociative anesthesia
Block NMDA receptor
345
Side effects of dissociative anesthetic
Cardiovascular stimulation, increased cerebral blood flow, vivid dreams, hallucinations
346
Neuroleptanesthesia can be produced by a combination of these two agents
Fentanyl and droperidol
347
Mechanism of action of local anesthetics
Block voltage-gated sodium channels
348
This condition may necessitate larger doses of local anesthetics because the drugs become ionized and cannot penetrate the neuronal membranes
Low pH
349
Almost all local anesthetics have this property and sometimes require the administration of vasoconstrictors to prolong activity
Vasodilation
350
The only local anesthetic with vasoconstrictive property, but due to abuse potential, only occasionally used for nasal surgery
Cocaine
351
This type of local anesthetic is more likely to cause hypersensitivy reactions
Ester-type (local anesthetic with one "I" in name)
352
Local anesthetic most widely used for obstetric anesthesia but causes the most cardiac depression
Bupivacaine
353
Side effect of most local anesthetics
CNS excitation
354
Common side effect of antipsychotics, MPTP (contaminant in illicit meperidine analog), and cholinergic excess
Drug-induced Parkinsonism
355
Two fluctuations in clinical response associated with long-term use of dopamine precursor
"Wearing off" and "on-off-phenomenon"
356
Inhibits of catechol-O-methyltransferase (COMT), used as adjunct to improve motor function in Parkinson's patients with fluctuations in clinical response
Entacapone, tolcapone
357
Ergot type 2 dopamine receptor (D2) agonist, used as adjunct to improve motor function in Parkinson's patients with fluctuations in clinical response
Bromocriptine
358
Non ergot type 2 dopamine receptors (D2) agonist, used for Parkinson's and restless legs syndrome
Pramipexole and ropinirole
359
An antiviral that enhances dopamine release from nigrostriatal neurons
Amantadine
360
Two centrally-acting anticholinergics useful for tremor and rigidity but have little effect on bradykinesia in patients with Parkinson's
Benztropine, trihexylphenidyl
361
Drug of choice indicated for familial or essential tremors
Propranolol
362
Two drugs that inhibit vesicle monoamine transporter used for Huntington's
Tetrabenazine, reserpine
363
An antipsychotic with dopamine receptor antagonist activity used for Huntington's
Haloperidol
364
Three centrally-acting cholinesterase inhibitors used for Alzheimer's
Donepezil, rivastigmine, galantamine
365
Noncompetitive antagonist of NMDA receptors used for Alzheimer's
Memantine
366
Complications of the gastrointestinal system associated with chronic alcohol use
Mallory-Weiss syndrome, hepatitis, cirrhosis, pancreatitis
367
The most common neurologic abnormality in chronic alcoholics
Neurologic deficits (Peripheral neuropathy)
368
Life-threatening alcohol withdrawal syndrome that peaks at 5 days after the last drink
Delirium tremens
369
Inhibits aldehyde dehydrogenase and used as deterrent for alcohol use
Disulfiram
370
Opioid receptor antagonist used to prevent alcohol abuse
Naltrexone
371
Competes for alcohol dehydrogenase and is used in methanol or ethylene glycol poisoning
Fomepizole, ethanol
372
Most commonly abused opioids
Heroin, morphine, oxycodone
373
Sweating, dilated pupils, piloerection, and flu-like symptoms are symptoms of withdrawal from this class of drugs
Opioid
374
Opioids used for long-term maintenance from opioid withdrawal
Methadone, buprenorphine
375
Most widely abused sedative hypnotics
Short-acting barbiturates (pentobarbital)
376
Four major CNS stimulant drugs of abuse
Caffeine, nicotine, cocaine, amphetamines
377
CNS stimulant that acts by inhibiting reuptake of neurotransmitters; may cause pupil dilation, alter tactile sensation, irregular breathing, and cardiac toxicity
Cocaine
378
Amphetamine derivatives commonly abused
Methamphetamine (crystal meth), MDMA (methylenedioxymeth-amphetamine, or ecstasy)
379
Drug of abuse that was developed as a dissociative anesthetic; intoxication leads to both horizontal and vertical nystagmus, analgesia, psychosis, delirium, and seizures
PCP (phencyclidine, or angel dust)
380
Use of all antipsychotic medication in this group of patients is associated with increased risk of deaths
Elderlyl with dementia-related psychosis
381
Antipsychotics that repress primarily the positive symptoms of schizophrenia
Typical antipsychotics
382
Two low potency, typical antipsychotic drugs
Chlorpromazine, thioridazine
383
Typical antipsychotic associated with retinopathy and cardiac toxicity
Thioridazine
384
Three high potency, typical antipsychotic drugs
Haloperidol, fluphenazine, trifluoperazine
385
Typical antipsychotic that can also be used for Tourette syndrome
Haloperidol
386
Treatment for drug-induced acute extrapyramidal symptoms
Benztropine, diphenhydramine
387
Advantage of atypicals over typical antipsychotics
Less extrapyramidal symptoms, more effect against negative symptoms of schizophrenia
388
Two atypical antipsychotics that can cause weight gain
Clozapine, olanzapine
389
Two atypical antipsychoics that can prolong the QT interval
Risperidone, ziprasidone
390
Atypical antipsychotic that can increase prolactin levels and cause gynecomastia and irregular menstruation in men and women, respectively
Risperidone
391
Atypical antipsychotic that can also be used to treat irritability in autistic children
Aripiprazole
392
Tricyclic antidepressants
-iptyline, -ipramine, doxepin, amoxapine
393
Mechanism of action of tricyclic antidepressants
Block serotonin and norepinephrine reuptake
394
Common side effects of tricyclic antidepressants
Autonomic (block muscarinic and α1), sedation
395
Tricyclic secondary amines that produce less sedation and autonomic side effects (compared with tricyclic tertiary amines)
Nortriptyline, desipramine
396
Tricyclic antidepressant used for enuresis
Imipramine
397
Tricyclic antidepressant used in obsessive compulsive disorder
Clomipramine
398
Tricyclic antidepressant with antihistamine effect and is indicated for insomnia
Doxepin
399
Class of antidepressants that has fewer sedative and autonomic side effects than tricyclic antidepressants and indicated for panic disorder, generalized anxiety disorder, social phobias, bulimia, obsessive compulsive behavior, and post-traumatic stress disorder
Selective serotonin reuptake inhibitors (SSRI)
400
Four selective serotonin reuptake inhibitors
Fluoxetine, paroxetine, sertraline, citalopram
401
Two selective serotonin-norepinephrine reuptake inhibitors
Duloxetine, venlafaxine
402
Class of drugs that is most useful in patients with anxiety, hypochondriasis, and depression that is refractory to other antidepressants
Monamine oxidase inhibitors
403
Mechanism of action of isocarboxazid, phenelzine, and tranylcypromine
Irreversible inhibition of monoamine oxidase A and B
404
Mechanism of action of selegiline
Selectively inhibits monoamine oxidase B
405
A fatal condition that results from combination of monoamine oxidase inhibitors with tyramine-containing foods
Hypertensive crisis
406
Antidepressant that inhibits alpha 2, 5HT-2, and 5HT-3 receptors to increase release of norepinephrine and serotonin
Mirtazapine
407
Major route of elimination for Lithium
Kidneys
408
Antineoplastic pyrimidine analog that inhibits thymidylate synthetase
5-fluorouracil (5-FU)
409
Antineoplastic pyrimidine analog that inhibits DNA polymerase
Cytarabine
410
Serious side effect associated with cytarabine
Pancytopenia
411
Three antineoplastic purine analogs that inhibit purine synthesis
Azathioprine, 6-mercaptopurine, 6-thioguanine
412
Drug used concurrently with antineoplastics to reduce renal precipitation of urates
Allopurinol
413
Inhibits microtubule formation by binding to β-tubulin; dose-limiting side effect is bone marrow suppression
Vinblastine
414
Inhibits microtubule formation by binding to β-tubulin; dose-limiting side effect is neurotoxicity
Vincristine
415
Two prodrugs, that after liver bioactivation, bind to N7 nitrogen of guanine and cross-link DNA
Cyclophosphamide, ifosfamide
416
Serious side effect of cyclophosphamide and ifosfamide due to generation of acrolein
Hemorrhagic cystitis
417
Agent that is used to bind acrolein and prevent drug-induced hemorrhagic cystitis
Mesna
418
Akylating agent that has greater activity against myeloid cells than lymphoid cells; serious side effects include myelosuppression and pulmonary fibrosis
Busulfan
419
Two anthracyclines that chelate DNA, form free radicals, and cause dose-limiting cardiotoxicity
Daunorubicin, doxorubicin
420
DNA intercalating agent useful for treatment of solid tumors in children
Dactinomycin (actinomycin D)
421
Antineoplastic with G2 phase cell cycle selectivity
Bleomycin
422
Ribonucleotide reductase inhibitor with S phase cell cycle selectivity that is used for management of sickle cell anemia
Hydroxyurea
423
Platinum-derivatives that form DNA intrastrand cross-links; causes dose-limiting nephrotoxicity and ototoxicity
Cisplatin, carboplatin
424
Two antineoplastics that inhibit topoisomerase I
Irinotecan, topotecan
425
Two antineoplastics that inhibit topoisomerase II
Etoposide, teniposide
426
Inhibits BCR-ABL tyrosine kinase expressed by the Philadelphia chromosome in chronic myeloid leukemia
Imatinib
427
Inhibits BRAF kinase in melanomas with BRAF V600E mutation
Vemurafenib
428
Chimeric monoclonal antibody against CD20 antigen found on non-Hodgkin lymphomas and normal B lymphocytes
Rituximab
429
Recombinant human monoclonal antibody against vascular endothelial growth factor (VEGF)
Bevacizumab
430
Recombinant human monoclonal antibody against human epidermal growth factor-2 (HER2) receptor; useful for breast cancer cells that overexpress HER2
Trastuzumab
431
Gonadotropin-releasing hormone agonist that can be used to inhibit leutinizing hormone secretion and testosterone production in men with advanced prostate cancer
Leuprolide
432
Two most commonly used glucocorticoids for cancer due to their lymphotoxic effects; may cause Cushing-like symptoms
Prednisone, prednisolone
433
Increase activity of cytoxic cells and indicated for hairy cell leukemia
Interferon alpha-2b
434
Agent used for hypochromic microcytic anemias
Ferrous sulfate
435
Agent used for megaloblastic anemia with neurological deficits
Vitamin B12
436
Agent used for neutropenia associated with cancer chemotherapy and bone marrow transplantation
Filgrastim (granulocyte colony-stimualting factor) and sargramostim (granulocyte-macrophage colony-stimulating factor)